title: Imatinib in patients with metastatic gastrointestinal stromal tumours relapsing after hepatic transplantation.
authors.forename: Emmanuelle
authors.initials: E
authors.lastname: Bompas
authors.forename: Olivier
authors.initials: O
authors.lastname: Boillot
authors.forename: Pierre-Paul
authors.initials: PP
authors.lastname: Bringuier
authors.forename: Jérôme
authors.initials: J
authors.lastname: Dumortier
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Blay
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D003240:Connective Tissue Diseases / Q000188:drug therapy*; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy*; D006801:Humans; D000068877:Imatinib Mesylate; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016031:Liver Transplantation; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D007166:Immunosuppressive Agents; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate